Previous Close | 100.82 |
Open | 101.30 |
Bid | 101.73 x 600 |
Ask | 102.39 x 100 |
Day's Range | 101.17 - 102.53 |
52 Week Range | 75.93 - 104.07 |
Volume | |
Avg. Volume | 1,070,508 |
Market Cap | 20.294B |
Beta (5Y Monthly) | 0.93 |
PE Ratio (TTM) | 69.93 |
EPS (TTM) | 1.46 |
Earnings Date | May 30, 2024 |
Forward Dividend & Yield | 0.02 (0.01%) |
Ex-Dividend Date | Jul 26, 2023 |
1y Target Est | 105.56 |
Subscribe to Yahoo Finance Plus to view Fair Value for COO
Key Insights Cooper Companies will host its Annual General Meeting on 19th of March Salary of US$1.05m is part of CEO...
SAN RAMON, Calif., Feb. 29, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced financial results for its fiscal first quarter ended January 31, 2024. Revenue increased 9% year-over-year to $931.6 million. CooperVision (CVI) revenue up 7% to $621.5 million, and CooperSurgical (CSI) revenue up 12% to $310.1 million.GAAP diluted earnings per share (EPS) of $0.41, down $0.02 or 5% from last year's first quarter.Non-GAAP diluted EPS of $0.
The Cooper Companies (COO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.